Entity > Corporation > US > New York City New York > Pulmatrix

About Pulmatrix

Pulmatrix is a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious disease using its patented iSPERSE™ technology.

Pulmatrix Discovers and Develops iSPERSE: Pulmatrix discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States.

Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE™ (inhaled Small Particles Easily Respirable and Emitted), which enables the delivery of small or large molecules to the lungs by inhalation for local or systemic applications. The iSPERSE™ powders are designed as small, dense particles with highly efficient dispersibility and delivery to the respiratory tract. iSPERSE™ powders can be used with a range of dry powder inhalation technologies and formulated with a wide range of drugs including small molecules and biologics.

Partnering with Pharmaceutical Companies: Pulmatrix partners with India's second largest pharmaceutical company, Cipla, for the Pulmazole™ antifungal program for the treatment of Allergic Bronchopulmonary Aspergillosis (ABPA), with Nocion Therapeutics to explore new technologies to enable and improve inhaled drug delivery, and with Sensory Cloud to develop and commercialize a potential nasal prophylaxis and anti-contagion product for COVID -19.

Pulmatrix Mission Prioritizes iSPERSE Technology: Pulmatrix is committed to developing and commercialising novel and transformational medicines for patients around the world. In doing so, the company uses its proprietary iSPERSE™ technology to optimally deliver both respiratory and non-respiratory therapies through the respiratory system.

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Pulmatrix

Company Attribute Value
Address StreetAddress: 99 Hayden Ave Ste 390, AddressLocality: Lexington, AddressRegion: Massachusetts, PostalCode: 2421, AddressCountry: United States
Founding Date 2003
Name Pulmatrix
Number Of Employees 24
Revenue $4,939,000 USD
Ticker Symbol NASDAQ: PULM
Url pulmatrix
Linkedin linkedin
Twitter twitter
Google google
Wikidata wikidata



New York City, US
13 Jul 2024

New York City, US
13 Jul 2024


Page: 1 Desktop | Laptop Devices

With iSPERSE ™ technology, PULMATRiX is expanding therapeutic care for patients with serious disease through a new generation of PULMONARY-DELIVERED ...
https://finance.yahoo.com › quote › PULM
Pulmatrix, Inc. (PULM) Stock Price, News, Quote & History
Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and ...
https://www.prnewswire.com › news-releases › pulmatrix...
Pulmatrix Announces Cross License Agreement and ...
May 29, 2024 — Pulmatrix transferring leased building, all leasehold improvements, laboratory equipment and other related personal property in exchange for ...
https://www.prnewswire.com › news-releases › pulmatrix...
Pulmatrix Announces First Quarter 2024 Financial Results ...
May 10, 2024 — After the study wind down, Pulmatrix will bear no further financial responsibility for the development of PUR1900 and will receive 2% royalties ...
https://www.marketwatch.com › ... › United States
PULM Stock Price | Pulmatrix Inc. Stock Quote (U.S.: Nasdaq)
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the development and discovery of novel inhaled therapeutics products. The company ...
Pulmatrix Inc.
PULMATRIX is committed to the development and commercialization of novel and transformational medicines for patients all over the world, ...
https://www.wsj.com › Quotes
PULM | Pulmatrix Inc. Stock Price & News
View the latest Pulmatrix Inc. (PULM) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Related Searches
Related Searches
Pulmatrix buyout
Pulmatrix careers
Pulmatrix Bedford MA
Knowledge Panel
Knowledge Panel

Pulmatrix (Pharmaceutical company)


  • Stock price : PULM (NASDAQ) $2.12 +0.02 (+0.95%)Jul 12, 4:00 PM EDT - Disclaimer
  • Headquarters : Bedford, MA
  • Date founded : 2003

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 193763